CASI PHARMACEUTICALS, INC. (CASIF) Operating cash flow 2020–2025
CASI PHARMACEUTICALS, INC. (CASIF) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$20.8MFY2025 · since FY2020: -$25.9M → -$20.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$20.8M | +29.0% |
| FY2024 | -$29.2M | -46.4% |
| FY2023 | -$20.0M | +5.3% |
| FY2022 | -$21.1M | +21.4% |
| FY2021 | -$26.8M | -3.7% |
| FY2020 | -$25.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice